ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,778.00
      -0.69%
      Dow Jones
      44,544.66
      -0.75%
      Brent Oil
      76.385
      0.00%
      Bitcoin
      102,385.53
      -0.03%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Radiopharm Theranostics Ltd (RADX) Quote

      Radiopharm Theranostics Ltd

      Radiopharm Theranostics Ltd (RADX)

      NASDAQ
      4.64
      -0.11
      (-2.32%)
      Closed February 01 4:00PM
      Delayed by 15 minutes
      4.64
      0.00
      (0.00%)
      After Hours: 5:42PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      4.64
      Bid
      4.50
      Ask
      5.46
      Volume
      20,444
      4.64 Day's Range 5.085
      0.00 52 Week Range 0.00
      Previous Close
      4.75
      Open
      5.00
      Last Trade
      1
      @
      4.96
      Last Trade Time
      Average Volume (3m)
      -
      Financial Volume
      $ 97,575
      VWAP
      4.7728

      Ask ADVFN Intelligence (AI)

      RADX Latest News

      More News

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      January 30 2025
      Edgar (US Regulatory)

      Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

      Private placement to radiopharmaceutical industry leader Lantheus, for US$5.0 millionPlacement at A$0.060 per share, representing a premium of 150% to the last closing price of A$0.024Lantheus...

      January 10 2025
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      January 10 2025
      Edgar (US Regulatory)

      Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

      RAD to advance the clinical development of Lantheus innovative radiopharmaceuticals in Australia Initial collaboration will focus on a Phase 1 imaging trialFinancial incentives to be paid to RAD...

      December 30 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 30 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 20 2024
      Edgar (US Regulatory)

      RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

      Ethics approval received in Australia for the initiation of RAD’s Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric CancersThe Phase 1 First-In-Human study is designed to assess the...

      December 20 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 19 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 18 2024
      Edgar (US Regulatory)

      Form EFFECT - Notice of Effectiveness

      December 16 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      RADX - Frequently Asked Questions (FAQ)

      What is the current Radiopharm Theranostics share price?
      The current share price of Radiopharm Theranostics is $ 4.64
      What is the 1 year trading range for Radiopharm Theranostics share price?
      Radiopharm Theranostics has traded in the range of $ 0.00 to $ 0.00 during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		729.72M
      REBNReborn Coffee Inc
      $ 3.31
      (63.05%)
      		55.54M
      FCUVFocus Universal Inc
      $ 5.87
      (56.62%)
      		1.73M
      SOPASociety Pass Inc
      $ 1.54
      (56.50%)
      		13.82M
      CYCNCyclerion Therapeutics Inc
      $ 3.92
      (54.33%)
      		82.39M
      ENVBEnveric Biosciences Inc
      $ 2.0899
      (-46.41%)
      		1.57M
      NIVFNewGenIvf Group Ltd
      $ 0.1489
      (-42.51%)
      		14.8M
      GLSTGlobal Star Acquisition Inc
      $ 8.83
      (-39.10%)
      		23.89k
      PRPHProPhase Labs Inc
      $ 0.2633
      (-38.02%)
      		872.46k
      SPGCSacks Parente Golf Inc
      $ 0.5601
      (-37.86%)
      		7.27M
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		729.72M
      NVDANVIDIA Corporation
      $ 120.07
      (-3.67%)
      		388.54M
      RIMEAlgorhythm Holdings Inc
      $ 0.02565
      (5.12%)
      		338.75M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0355
      (-11.25%)
      		236.29M
      CLEUChina Liberal Education Holdings Ltd
      $ 0.1938
      (30.77%)
      		234.8M

      RADX Discussion

      View Posts
      Invest-in-America Invest-in-America 2 months ago
      RADX: Whelp, for what it's worth, here's the new RADX iHub BOARD!!!! (They make cute DIAGNOSTIC --- & potentially THERAPEUTIC, as well --- Medical gadgets that can enter tiny, obscure, sites in our Homo sapiens BODIES; and then hopefully determine what-the-heck bad things are transpiring in there, & maybe fix them to boot!!!)
      👍️0

      Your Recent History

      NASDAQ
      RADX
      Radiopharm Theranostics
      LSE
      JSED
      Jpm Eu Sri Pa D
      LSE
      CNUA
      Ubsetf China A
      TSXV
      ROOF
      Northstar Clean Technolo...
      NASDAQ
      SJ
      Scienjoy
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads